Natixis Advisors LLC trimmed its position in Encompass Health Corporation (NYSE:EHC – Free Report) by 26.1% in the fourth quarter, Holdings Channel reports. The firm owned 116,128 shares of the company’s stock after selling 40,924 shares during the quarter. Natixis Advisors LLC’s holdings in Encompass Health were worth $12,326,000 as of its most recent SEC filing.
A number of other hedge funds have also bought and sold shares of EHC. Royal Bank of Canada grew its stake in Encompass Health by 21.5% in the first quarter. Royal Bank of Canada now owns 88,470 shares of the company’s stock worth $8,960,000 after purchasing an additional 15,677 shares in the last quarter. Millennium Management LLC grew its stake in Encompass Health by 38.4% in the first quarter. Millennium Management LLC now owns 92,197 shares of the company’s stock worth $9,338,000 after purchasing an additional 25,574 shares in the last quarter. Caxton Associates LLP acquired a new position in Encompass Health in the first quarter worth about $259,000. Walleye Capital LLC grew its stake in Encompass Health by 667.6% in the second quarter. Walleye Capital LLC now owns 6,522 shares of the company’s stock worth $800,000 after purchasing an additional 7,671 shares in the last quarter. Finally, Gamco Investors INC. ET AL acquired a new position in Encompass Health in the second quarter worth about $588,000. 97.25% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In other news, EVP Patrick William Tuer sold 682 shares of Encompass Health stock in a transaction that occurred on Monday, May 11th. The stock was sold at an average price of $104.56, for a total transaction of $71,309.92. Following the sale, the executive vice president owned 24,755 shares of the company’s stock, valued at approximately $2,588,382.80. The trade was a 2.68% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Treasurer Edmund Fay sold 11,937 shares of Encompass Health stock in a transaction that occurred on Monday, March 9th. The shares were sold at an average price of $107.00, for a total value of $1,277,259.00. Following the sale, the treasurer directly owned 89,325 shares in the company, valued at approximately $9,557,775. This trade represents a 11.79% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 1.80% of the company’s stock.
Wall Street Analyst Weigh In
View Our Latest Stock Analysis on EHC
Encompass Health Stock Performance
EHC opened at $104.39 on Friday. The business’s 50 day moving average is $103.79 and its 200-day moving average is $105.01. The stock has a market cap of $10.36 billion, a PE ratio of 17.43, a price-to-earnings-growth ratio of 2.27 and a beta of 0.72. The company has a current ratio of 1.17, a quick ratio of 1.17 and a debt-to-equity ratio of 0.76. Encompass Health Corporation has a twelve month low of $92.77 and a twelve month high of $127.99.
Encompass Health (NYSE:EHC – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $1.60 earnings per share for the quarter, beating analysts’ consensus estimates of $1.51 by $0.09. The company had revenue of $1.59 billion for the quarter, compared to analysts’ expectations of $1.57 billion. Encompass Health had a return on equity of 18.28% and a net margin of 10.04%.The business’s revenue for the quarter was up 9.0% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.37 earnings per share. Encompass Health has set its FY 2026 guidance at 5.890-6.110 EPS. On average, analysts predict that Encompass Health Corporation will post 5.97 earnings per share for the current year.
Encompass Health Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a dividend of $0.19 per share. This represents a $0.76 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend is Wednesday, July 1st. Encompass Health’s payout ratio is 12.69%.
Encompass Health Profile
Encompass Health Corporation is a leading provider of post‐acute healthcare services in the United States, operating a comprehensive network of inpatient rehabilitation hospitals and home health and hospice agencies. Its inpatient rehabilitation hospitals offer intensive therapy programs for patients recovering from conditions such as stroke, brain injury, spinal cord injury, cardiac and pulmonary disorders, and orthopedic procedures. Through its home health segment, Encompass Health delivers skilled nursing, physical therapy, occupational therapy and speech therapy to patients in the comfort of their homes, while its hospice services provide end‐of‐life care focused on symptom management and emotional support for patients and families.
Founded in 1984 as HealthSouth Corporation and rebranded as Encompass Health in 2018, the company has grown organically and through acquisitions to serve patients across more than 30 states.
See Also
- Five stocks we like better than Encompass Health
- Samsara Just Answered The AI Question—Is Wall Street Ready To Listen?
- IREN’s 800MW Bet Flips the AI Power Switch
- CrowdStrike Earnings Beat Sparks Selloff—Buy the Dip?
- Tesla’s EV Rebound Leaves Rivian and Lucid Facing a Tougher Investor Test
Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corporation (NYSE:EHC – Free Report).
Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.
